← Open Payments lookup

TERESA SPENCER: Open Payments

NPI 1801837026 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,470 in 176 payments from 17 companies in 2025. Trend: 2023 $3,352 · 2024 $2,870 · 2025 $3,470

Food & beverage: $3,470
CompanyPaymentsAmount
GlaxoSmithKline, LLC.50$913
AstraZeneca Pharmaceuticals LP29$784
Verona Pharma, Inc.20$280
Mallinckrodt Hospital Products Inc.13$259
GENZYME CORPORATION12$239
Boehringer Ingelheim Pharmaceuticals, Inc.11$197
Electromed, Inc.8$136
Regeneron Healthcare Solutions, Inc.5$125
Takeda Pharmaceuticals U.S.A., Inc.6$107
Insmed, Inc.4$85

Products named: NUCALA, TRELEGY ELLIPTA, AIRSUPRA, DUPIXENT, Ohtuvayre, ACTHAR, TEZSPIRE, BREZTRI.

Industry payments across MS — which companies pay providers there.